CanSino Biologics Inc. (6185.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 7.95B |
| Enterprise Value | 8B |
| P/E Ratio | 1,696.31 |
| PEG Ratio | -59.76 |
| Price/Sales Ratio | 8.23 |
| Price/Book Ratio | 2.54 |
| Enterprise/Revenue | 8.27 |
| Enterprise/EBITDA | 68.55 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0 |
| Operating Margin | -0 |
AD
Management Effectiveness
| Return On Assets | -0 |
| Return On Equity | -0 |
Income Statement
| Revenue | 1.03B |
| Revenue/Share | 4.54 |
| Gross Profit | 681.82M |
| EBITDA | 60.98M |
| Net Income | 27.15M |
| Diluted EPS | 0.11 |
Balance Sheet
| Total Cash | 2.07B |
| Total Cash/Share | 8.43 |
| Total Debt | 1.16B |
| Total Debt/Equity | 0.24 |
| Current Ratio | 4.11 |
| Book Value Per Share | 19.94 |
Price History
| 52-Week Change | -37.67 |
| 52-Week High | 56.55 |
| 52-Week Low | 19.22 |
| Moving Average 50 Days | 28.32 |
| Moving Average 200 Days | 36.92 |
Statistics
| Average Volume | 1.05M |
| Shares Outstanding | 350.09M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -23.46 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
